Our Prize Advisory Panel features experts in diagnostic tests, antibiotic resistance and global health. They will judge all entries and recommend potential winners to the Longitude Committee.

Below is the list of experts that are sitting on the Prize Advisory Panel. These are some of the most eminent professionals in their fields and will be responsible for the main judging of  Longitude Prize, as well as providing support and advice to the Longitude team and Committee.

Panel Members

  • Prof Dame Sally Davies

    Chief Medical Officer, Department of Health. Prize Advisory Panel Co-Chair

    Professor Dame Sally Davies - Chief Medical Officer, Department of Health

    Professor Dame Sally Davies was appointed Chief Medical Officer in 2010. She was a key figure in the development of the National Institute for Health Research, and is a member of the UK Health Innovation Council. Sally also chairs the UK Clinical Research Collaboration, and is a fellow of the Royal Society. In 2013, she was listed as the sixth most powerful woman in the UK by BBC Radio 4’s Woman’s Hour. She is the author of the recent book on anti-microbial resistance, “The Drugs Don’t Work".

  • Prof Peter Piot

    Director, London School of Hygiene and Tropical Medicine. Prize Advisory Panel Co-Chair

    Professor Piot is a distinguished expert in microbiology and epidemiology, and has played key roles in understanding some of the deadliest diseases affecting the world today. As well as co-discovering Ebola in 1976, he has made a huge contribution to bringing HIV/ AIDS to the forefront of global agendas; as well as time as President of the International AIDS Society he was the founding Executive Director of UNAIDS, and Under Secretary-General of the United Nations.

  • Prof Mike Sharland

    Professor of Paediatric Infectious Diseases, Lead Consultant Paediatrician, St George's University London. Prize Advisory Panel Co-Chair

    Professor Sharland is a consultant in paediatric infectious diseases at St George's University Hospitals NHS Foundation Trust. He has a specialist interest in paediatric antimicrobial prescribing. He heads the paediatric infectious diseases service for south London and chairs a national network for children with HIV. He leads the paediatric infectious diseases unit at St George's Hospital, one of the national training centres in PID in the UK. His research interest focus on optimising antimicrobial prescribing for children. He has published over 150 papers in this area.

  • Dr Till Bachmann

    Reader in Personalised Medicine in Infectious Diseases; Deputy Head of Division of Infection and Pathway Medicine, University of Edinburgh

    Till Bachmann is a Reader in Personalised Medicine in Infectious Diseases and Deputy Head of the Division of Infection and Pathway Medicine at The University of Edinburgh. He is an expert in point of care detection of infectious diseases and antimicrobial resistance, conducting research at the interface of biomarkers and novel detection modalities. Till fulfils a variety of industrial and institutional advisory roles worldwide.

  • Prof Chris Butler

    Professor of Primary Care Health Sciences, University of Oxford

    Chris Butler is professor of primary care in the Nuffield Department of Primary Care Health Sciences at the University of Oxford and Professorial Fellow at Trinity College. His main research interests are in common infections (especially the appropriate use of antibiotics and antibiotic resistance), and health behaviour change (especially adaptations of motivational interviewing in health care). 

  • Dr Paul Chapman

    Partner, Marks & Clerk LLP

    Paul has almost 20 years of experience in the IP profession with clients ranging from universities and SMEs to large multinational companies particularly in the biotechnology, chemistry and pharmaceutical fields. He has significant expertise in biologics including, antibody technology, stem cells, RNAi and vaccines.

  • Dr Patrick SM Dunlop

    Lecturer, Ulster University

    Patrick is a Lecturer within the Nanotechnology and Integrated BioEngineering Centre (NIBEC) at Ulster University. He is a chartered biologist with a strong academic background in applied biology and chemistry. Patrick’s research activities focus on the development of nanomaterials for disinfection and the design of biomedical sensors. Locally, Patrick is Chair of the NI AMR Network, a “One Health” focused multidisciplinary body bringing together academia, industry and government to discuss AMR issues and collaborate to find solutions.

  • Dr Abdul Ghafur

    Coordinator, "Chennai Declaration", Apollo Honorary Adjunct Associate Professor, Consultant in Infectious Diseases and Clinical Microbiology

    Dr. Ghafur is the primary author and coordinator of the “ Chennai Declaration”,  a document and initiative to tackle the challenge of antimicrobial resistance from an Indian perspective. He is also a Consultant and Adjunct Associate Professor in infectious diseases and Clinical Microbiology at the Apollo Hospitals, Chennai, India.

  • Prof Azra Ghani

    Chair in Infectious Disease Epidemiology - Imperial College London

    Azra Ghani leads the malaria modelling group within the Department of Infectious Disease Epidemiology at Imperial College London. Her research combines the use of mathematical models and statistical methods to understand the transmission dynamics and control of a range of infectious diseases of humans and animals. 

  • Prof Herman Goossens

    Head of the Department for Microbiology, Antwerp University Hospital

    Herman is a professor of Medical Microbiology at the University of Antwerp in Belgium and the director of the Laboratory of Clinical Biology of the University Hospital Antwerp. Herman Goossens received several honours and awards, including the American APUA (Alliance for the Prudent Use of Antibiotics) award in 2006. Herman has published more than 450 full papers in peer-reviewed scientific journals.

  • Martin Kiernan

    Research Fellow at the Richard Wells Research Centre at the University of West London and is Director of Clinical Research and Education for Gama Healthcare.

    Martin is a Research Fellow at the Richard Wells Research Centre at the University of West London and is Director of Clinical Research and Education for Gama Healthcare. Prior to this he was Nurse Consultant and Deputy Director of Infection Prevention and Control at Southport and Ormskirk NHS Trust in the North-West of England. He has worked in the field of infection prevention and control for 25 years in a variety of settings.

  • Dr Francis Moussy

    Leader - Diagnostics, World Health Organisation

    Francis Moussy joined the World Health Organization in 2009. He is currently leading projects to facilitate the development, access and use of diagnostics, that are suitable for Low-and-Middle Income Countries (LMICs). His current  diagnostic focus areas are open multipurpose diagnostic platforms, Ebola, Antimicrobial Resistance, HbA1c and technology transfer . Prior to joining WHO in March 2009, Dr Moussy worked as Professor and Deputy Director in the Brunel Institute for Bioengineering at Brunel University (West London), UK working on biosensors

  • Prof Kevin Outterson

    Professor of Health Law, Bioethics & Human Rights, Boston University

    Professor Outterson teaches health law and corporate law at Boston University, where he co-directs the Health Law Program. His research work focuses on the organization and finance of the health sector. Areas of specialization include global pharmaceutical markets, particularly antibiotics and other antimicrobials that can degrade in usefulness over time through resistance. He is an Associate Fellow at the Royal Institute of International Affairs (Chatham House) and a founding member of the Antimicrobial Resistance Working Group at the CDC.  

  • Prof Rosanna Peeling

    Professor and Chair of Diagnostics Research, London School of Hygiene and Tropical Medicine

    Rosanna Peeling is currently Professor and Chair of Diagnostics Research at the London School of Hygiene and Tropical Medicine (LSHTM) and Director of the International Diagnostic Centre. Trained as a medical microbiologist, Dr. Peeling had been Research Coordinator and Head of Diagnostics Research at the UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (WHO/TDR) in Geneva, Switzerland, and the Chief of the Canadian National Laboratory for Sexually Transmitted Diseases before assuming her current position.

  • Dr Teri Roberts

    Diagnostics Advisor, MSF Access Campaign

    An immunologist by training, with a background in TB research, Teri joined MSF's Access Campaign in 2011 as their Diagnostics Advisor. She worked on access issues to HIV and hepatitis diagnostics, and now fever and antimicrobial resistance, including improving access to existing diagnostic tests and influencing the design of future tests to better suit the needs of resource limited settings.

  • Prof Suzanne Skevington

    Professor of Health Psychology, University of Manchester

    Suzanne Skevington holds a Project Diamond Chair in Health Psychology at the University of Manchester where she directs the International Hub for Quality of Life Research (IHQoLR). She is a founder member of the newly established Manchester Centre for Health Psychology and quality of life Advisor to WHO, UNESCO, UNAIDS, OECD, UNEP and the UN. She received a Fulbright Scholarship (1995) to visit the School of Public Health, Univ. of Washington, Seattle, and was an Academic Visitor at Univ. of Oxford (Health Services Research) in 2004.

  • Prof Richard Smith

    Professor of Health System Economics, London School of Hygiene and Tropical Medicine

    Richard Smith is Professor of Health System Economics and Dean of the Faculty of Public Health and Policy at the London School of Hygiene and Tropical Medicine. He has 25 years experience examining the economics of various health issues, including 20 years work in the area of antimicrobial resistance.

  • Dr Diana Tay

    Business Development Manager, Innovations, Wellcome Trust

    Diana Tay works in Innovations, Wellcome Trust, which aims to impact healthcare by funding R&D of healthcare innovations. She is responsible for the management of two translational funding schemes and provides oversight on a portfolio of funded awards across a broad range of healthcare innovations, including in diagnostics for infectious diseases in developing countries and worldwide. Prior to joining the Trust, she worked as Business Development Director, GSK, and as Head of Search and Selection, Asia, BD&L at Novartis Vaccines.

  • Rob Taylor

    Program Officer – Global Health Integrated Development, Bill and Melinda Gates Foundation

  • Prof Matthew Thompson

    Professor of Family Medicine, Vice Chair for Research, University of Washington

    Matthew Thompson is a Professor of Family Medicine, Global Health and Pediatrics at the University of Washington in Seattle, and formerly a GP and Director of the Oxford Center for Monitoring and Diagnosis/ NIHR Diagnostic Evidence Cooperative in England. He is an expert in new diagnostic technology evaluation and implementation in primary care settings, with a focus on point of care testing’

  • Dr Penny Wilson

    Innovation Platform Leader, Stratified Medicine, Innovate UK

    Dr Penny WIlson

    As part of Innovate UK’s Health & Care team, Penny oversees the organisation’s Stratified Medicine programme which aims to realise the UK’s potential in the area. Penny has spent ~22 years in the Diagnostics Industry in a variety of senior technical and strategic roles.

  • Prof Lucy Yardley

    Professor of Health Psychology, Director of the Centre for Applications of Health Psychology (CAHP) , University of Southampton

    Lucy Yardley is Professor of Health Psychology at the University of Southampton and Director of the Centre for Applications of Health Psychology (CAHP). Her current major research focus is on using the internet to support self-management of health. She pioneered the development of the unique ‘LifeGuide’ open source software for developing web-based intervention, and is now leading the ‘UBhave’ programme to develop software for creating interventions for mobile phones.

Panel Members